EFEmma Francis

Emma Francis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emma Francis has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early interventions for first onset of symptoms of mental health conditions: an umbrella review of systematic reviews

    by Jasmine Lee, Phoebe Barnett, Jialin Yang, Rebecca Appleton, Brynmor Lloyd-Evans, Jane Hahn, Nathalie Rich, Emma Francis, Lizzie Mitchell, Eva Driskell, et al.

    Background Early intervention following mental health symptom onset has great potential in reducing long-term burden on individuals, families and friends, and society. The main focus in service development and research has been on early intervention in psychosis, but advances have also been made for other mental health difficulties such as eating disorders, anxiety and depression. We aimed to take stock of the available evidence regarding effectiveness, implementation, and experiences of care for early intervention approaches through a systematic umbrella review. Methods We included systematic reviews of complex early intervention strategies including more than one component, for mental health conditions with typical onset in young people under 25. We searched 4 databases (January 2019-April 2024) and synthesised results from eligible reviews using a narrative approach. Quality was assessed using AMSTAR 2. We excluded reviews on At Risk Mental States for psychosis as this is an extensive literature that has been the sole focus of umbrella reviews. Results Sixteen reviews were included, with ten covering early intervention for psychosis, three for eating disorders, one for bipolar disorder and two for transdiagnostic early intervention approaches. Reviews of early intervention for psychosis suggest that intensive approaches can improve recovery rates following first presentation to services, although the success of initiatives aimed at reducing duration of untreated symptoms is less consistent. We found little systematically synthesised evidence of good quality regarding other diagnoses, although some early indications of success with eating disorders were described. Stigma and lack of knowledge or support act as barriers to rapid access, while insufficient service resources and staffing were barriers to effective intervention delivery. Conclusions Despite its high importance in reducing the global burden of mental ill-health, evidence on how to intervene early following symptom onset remains limited (as assessed via systematic reviews), especially for conditions other than psychosis. For psychosis, some approaches now warrant attention to widespread implementation. Innovative approaches for eating disorders have been developed, but there is still a pressing need for treatments supported by substantial and robust trials. Further systematic reviews would be desirable for conditions including depression and anxiety, bipolar disorder, and “personality disorder”.


  • Open Access

    A Systematic Review of Long-term Antidepressant Outcomes in Comorbid Depression and Type 2 Diabetes

    by Annie Jeffery, Joshua E. J. Buckman, Emma Francis, Kate Walters, Ian C. K. Wong, David Osborn, Joseph F. Hayes

    Background Depression is a common and chronic comorbidity affecting approximately one in four people with type 2 diabetes (T2DM), and often lasting several years. Past systematic reviews have been unable to identify evidence for long-term (12+ months) antidepressant treatment outcomes in comorbid depression and type 2 diabetes. These reviews are >10years old, included only randomised controlled trials or had limited search strategies. We aimed to systematically review observational studies for long-term outcomes of antidepressant treatment in adults with comorbid depression and T2DM, including broader, up-to-date searches. Methods and findings This review was pre-registered on PROSPERO (CRD42020182788). We searched seven databases using terms related to depression, T2DM and antidepressant medication. From 14,389 reports retrieved, 63 were screened at full text stage and 0 met inclusion criteria. The reasons for exclusion at full text stage were: Studies did not meet inclusion criteria for antidepressant treatment (n = 50); studies did not meet inclusion criteria for T2DM (n = 36); studies did not meet inclusion criteria for depression (n = 29); studies did not include follow-up time (n = 25); studies did not meet inclusion criteria for observational study (n = 14); studies did not include any measurable outcomes (n = 5); studies did not include a suitable comparison (n = 3). Conclusions We found no evidence concerning long-term outcomes of antidepressant treatment in individuals with comorbid depression and T2DM. Insufficient ascertainment of antidepressant prescription, case identification, and short follow-up times are the primary reasons for this. Research is urgently required to determine long-term outcomes associated with antidepressant treatment in this patient group.


  • Open Access

    Incidence of suicidality in people with depression over a 10-year period treated by a large UK mental health service provider

    by Emma R. Francis, Daniela Fonseca de Freitas, Craig Colling, Megan Pritchard, Giouliana Kadra-Scalzo, Natalia Viani, Jaya Chaturvedi, Tom R. Denee, Cicely Kerr, Mitesh Desai, et al.

    We describe the incidence of suicidality (2007–2017) in people with depression treated by secondary mental healthcare services at South London and Maudsley NHS Trust (n = 26 412). We estimated yearly incidence of ‘suicidal ideation’ and ‘high risk of suicide’ from structured and free-text fields of the Clinical Record Interactive Search system. The incidence of suicidal ideation increased from 0.6 (2007) to 1 cases (2017) per 1000 population. The incidence of high risk of suicide, based on risk forms, varied between 0.06 and 0.50 cases per 1000 adult population (2008–2017). Electronic health records provide the opportunity to examine suicidality on a large scale, but the impact of service-related changes in the use of structured risk assessment should be considered.


  • Biographical films as a person‐centered approach to reduce neuropsychiatric symptoms of dementia in residential care: A feasibility study

    by Emma R. Francis, Jared G. Smith, Mustabshira Qayyum, Jessica Lee, Philip Woodgate, Robert M. Lawrence

    Objective: Neuropsychiatric symptoms are a major component of dementia irrespective of severity or subtype. We aimed to determine the feasibility of biographical films to reduce neuropsychiatric symptoms in people with moderate to severe dementia over a 32‐week period.Method: A total of 11 people with dementia situated in a residential care home took part in this mixed‐method feasibility study. Carers reported neuropsychiatric symptoms of residents at three time‐points, and their experience of the study was obtained at a feedback session.Results: There was a significant reduction in neuropsychiatric symptoms in residents with neuropsychiatric impairment from baseline to the end of study (p = .042; d = .98). Thematic analysis identified three major themes: Triggered memories, knowledge gained to support care, and perceived changes in the resident.Conclusion: The findings suggest that it is feasible to use biographical films long‐term to reduce neuropsychiatric symptoms of dementia, alongside routine care.


  • Hospitalisation and length of hospital stay following first-episode psychosis: systematic review and meta-analysis of longitudinal studies

    by Olesya Ajnakina, Brendon Stubbs, Emma Francis, Fiona Gaughran, Anthony S. David, Robin M. Murray, John Lally

    Background: Reducing hospitalisation and length of stay (LOS) in hospital following first episode psychosis (FEP) is important, yet reliable measures of these outcomes and their moderators are lacking. We conducted a systematic review and meta-analysis to investigate the proportion of FEP cases who were hospitalised after their first contact with services and the LOS in a hospital during follow-up.Methods: Studies were identified from a systematic search across major electronic databases from inception to October 2017. Random effects meta-analyses and meta-regression analyses were conducted.Results: 81 longitudinal studies encompassing data for 23 280 FEP patients with an average follow-up length of 7 years were included. 55% (95% CI 50.3–60.5%) of FEP cases were hospitalised at least once during follow-up with the pooled average LOS of 116.7 days (95% CI 95.1–138.3). Older age of illness onset and being in a stable relationship were associated with a lower proportion of people who were hospitalised. While the proportion of hospitalised patients has not decreased over time, LOS has, with the sharpest reduction in the latest time period. The proportion of patients hospitalised during follow-up was highest in Australia and New Zealand (78.4%) compared to Europe (58.1%) and North America (48.0%); and lowest in Asia (32.5%). Black ethnicity and longer duration of untreated psychosis were associated with longer LOS; while less severe psychotic symptoms at baseline were associated with shorter LOS.Conclusion: One in two FEP cases required hospitalisation at least once during a 7-year follow-up with an average length of hospitalisation of 4 months during this period. LOS has declined over time, particularly in those countries in which it was previously longest.